Preclinical Medical Device Testing Services Market: Surging Towards a Projected US$ 6.63 Billion Valuation in 2032

According to Future Market Insights’ most recent industry report, the worldwide preclinical medical device testing services market sales is expected to produce US$ 6.72 billion by 2022, up from US$ 6 billion in 2021. Between 2022 and 2032, the market is projected to develop at a surprising double-digit compound annual growth rate (CAGR) of 12%, creating a gain of US$ 20.87 billion. The government’s enforcement of strict legislation to assure safety standards is credited with the market’s rise.

The Preclinical Medical Device Testing Services Market is currently experiencing a surge, indicative of the growing emphasis on rigorous evaluation and validation of medical devices before reaching the market. These services play a crucial role in ensuring the safety, efficacy, and compliance of medical devices with regulatory standards. As technological advancements in the healthcare industry continue to introduce innovative medical devices, the demand for comprehensive preclinical testing services is on the rise. Stakeholders in the market, including testing laboratories and service providers, are actively engaged in meeting the evolving regulatory landscape and industry standards. The Preclinical Medical Device Testing Services Market acts as a critical checkpoint in the product development process, contributing to the overall reliability and performance of medical devices in clinical settings.

Get a Sample Copy of Report:https://www.futuremarketinsights.com/reports/sample/rep-gb-14994

Integration of artificial intelligence along with Internet of Things is playing a key role in advancing preclinical medical device testing services. In addition, the growing burden of treating diseases at an early stage is creating opportunities for the development of preclinical medical device testing services. Manufacturers too are researching and analyzing preclinical devices to solve problems related to the same at an early stage. This, in turn, is driving the demand for preclinical medical device testing services.

On the contrary, incompatible sterilization measures along with equipment sensitivity is derailing the progress of the market. In addition, approvals of preclinical medical devices differ from region to region. This, in turn, is hampering the growth of the overall market.

Key Takeaways:

• Global preclinical medical device testing services market is expected to flourish 3x from 2022 to 2032
• Microbiology and sterility testing expected to possess a market share for 35%
• U.S projected to lead the market by expanding at a CAGR of 18% during the forecast period.
• India expected to register a CAGR of 13% for preclinical medical device testing services in the assessment period 2022 to 2032
• Switzerland to be an emerging hub across Europe, expected to reflect a 10% value CAGR until 2032

Competitive Landscape

Key market players in the preclinical medical device testing services are Eurofins Scientific, Nelson Labs, North American Science Associates, Inc, WUXI APPTEC, SGS SA, Labcorp, TÜV SÜD AG, Sterigenics International LLC, Pace Analytical Services LLC, Intertek Group Plc, Charles River Laboratories International, Inc. Some of the recent key developments among the players are:

• In February 2022, Eurofins acquired Genetic Testing Service JSC from Vietnam. Through this expansion, the company is planning to expand its presence in Asia and strengthen its global network of advanced genetic testing.
• In September 2021, Nelson Labs and Sterigenics have collaborated to open a state of art laboratory and expand sterilization facilities to meet growing customer demand in Europe.

More Valuable Insights Available

FMI, in its new offering, presents an unbiased analysis of the global preclinical medical device testing services market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights by Service (Biocompatibility Tests, Chemistry Test, Microbiology & Sterility Testing), & Region Forecast till 2032

Key Companies:

• SGS SA
• Eurofins Scientific
• Intertek Group Plc
• WUXI APPTEC
• TÜV SÜD AG
• Sterigenics International LLC
• Nelson Labs
• North American Science Associates Inc.
• Charles River Laboratories International Inc.
• Pace Analytical Services LLC

Request Report Methodology:https://www.futuremarketinsights.com/request-report-methodology/rep-gb-14994

Key Segments:

Preclinical Medical Device Testing Services Market by Service:

• Preclinical Biocompatibility Medical Device Tests
• Preclinical Medical Device Chemistry Test
• Preclinical Medical Device Microbiology & Sterility Testing
  • Bioburden Determination
  • Pyrogen & Endotoxin Testing
  • Sterility Test and Validation
  • Antimicrobial Activity Testing
  • Others
• Preclinical Medical Device Package Validation

Preclinical Medical Device Testing Market by Region:

• North America Preclinical Medical Device Testing Services Market
• Latin America Preclinical Medical Device Testing Services Market
• Europe Preclinical Medical Device Testing Services Market
• Asia Pacific Preclinical Medical Device Testing Services Market
• Middle East & Africa Preclinical Medical Device Testing Services Market

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube